The Mesothelioma Center News
Gene Therapy Clinical Trial for Mesothelioma Moving Forward
- by Tim Povtak
- Research & Clinical Trials
- Sep 23, 2020
A much-anticipated, phase III clinical trial studying the use of gene therapy to combat pleural mesothelioma cancer has made a promising start. Interest is growing in what many believe…
Read More
Mesothelioma Trial to Test Cancer Vaccine with Immunotherapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 14, 2020
A research team at Oslo University Hospital in Norway has opened a mesothelioma clinical trial using the novel UV1 cancer vaccine alongside a promising immunotherapy combination. UV1 is a…
Read More
Peer Review Finds EPA’s Asbestos Risk Evaluation Flawed
- by Tim Povtak
- Asbestos Exposure & Bans
- Sep 2, 2020
The Science Advisory Committee on Chemicals found considerable failings and an underestimation of danger to the general public in a draft risk evaluation of asbestos submitted earlier this year…
Read More
Georgia-Pacific Pledges $1B to Bestwall Asbestos Trust Fund
- by Tim Povtak
- Asbestos Exposure & Bans
- Aug 25, 2020
Georgia-Pacific has pledged $1 billion to fund an asbestos trust for bankrupt affiliate Bestwall LLC, clearing the path to a settlement of longstanding liability claims involving mesothelioma cancer. Bloomberg…
Read More
New Lung Cancer Trial Could Benefit Mesothelioma Patients
- by Sean Marchese
- Research & Clinical Trials
- Aug 19, 2020
Pharmaceutical giant Merck has teamed up with Novocure to test its cornerstone immunotherapy, pembrolizumab (Keytruda), alongside Tumor Treating Fields. The new phase II clinical research trial is focusing on…
Read More
Immunotherapy Combination Extends Mesothelioma Survival
- by Tim Povtak
- Research & Clinical Trials
- Aug 11, 2020
Standard-of-care treatment for unresectable pleural mesothelioma cancer could be changing soon, sparked by a recently completed international study of a novel immunotherapy combination. Patients in the randomized mesothelioma…
Read More
Mesothelioma Clinical Trials Resume After COVID-19 Disruption
- by Sean Marchese
- Research & Clinical Trials
- Aug 10, 2020
When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold. As businesses begin to reopen…
Read More
Mesothelioma T-Cell Therapy Shows Early Effectiveness in Trial
- by Tim Povtak
- Research & Clinical Trials
- Aug 4, 2020
A mesothelioma clinical trial involving genetically modified T cells has opened to considerable acclaim, shrinking tumors in the first five patients who were treated. The phase I portion of the…
Read More
Mesothelioma Specialty Centers Rank on 2020 Best Hospitals List
- by Tim Povtak
- Treatment & Doctors
- Jul 29, 2020
For the sixth consecutive year, University of Texas MD Anderson Cancer Center in Houston was named the top Adult Cancer Hospital in America by U.S. News & World Report.
Read More
Study Shows Peritoneal Mesothelioma Surgery Underutilized
- by Tim Povtak
- Research & Clinical Trials
- Jul 28, 2020
The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a…
Read More
